# Cardiovascular Outcomes of Low Testosterone

> **NCT02758431** · NA · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 232 (actual)

## Conditions studied

- Hypogonadism

## Interventions

- **DRUG:** Acyline
- **DRUG:** Placebo Gel
- **DRUG:** Placebo Tablet
- **DRUG:** Testosterone Gel
- **DRUG:** Arimidex

## Key facts

- **NCT ID:** NCT02758431
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-01
- **Primary completion:** 2023-01-04
- **Final completion:** 2023-01-04
- **Target enrollment:** 232 (ACTUAL)
- **Last updated:** 2024-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02758431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02758431, "Cardiovascular Outcomes of Low Testosterone". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02758431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*